Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte

Nephroprotective Effect of Heparanase in Experimental Nephrotic Syndrome

(2015) Suheir Assady et al.   PLoS One

Vitamin D Down-Regulates TRPC6 Expression in Podocyte Injury and Proteinuric Glomerular Disease

(2013) Ramon Sonneveld et al.   AMERICAN JOURNAL OF PATHOLOGY

Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review

(2013) M. H. de Borst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The role of heparanase and the endothelial glycocalyx in the development of proteinuria

(2013) Marjolein Garsen et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy

(2013) Yu Bo Yang Sun et al.   PLoS One

1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss

(2012) Min-shu Zou et al.   International Journal of Medical Sciences

Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

(2012) Ravi Thadhani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification of the vitamin D receptor in various cells of the mouse kidney

(2012) Yongji Wang et al.   KIDNEY INTERNATIONAL

Oral Calcitriol for Reduction of Proteinuria in Patients With IgA Nephropathy: A Randomized Controlled Trial

(2011) Li-Jun Liu et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms

(2011) Mark R. Haussler et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice

(2011) N. Gil et al.   DIABETES

Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice

(2011) Immanuel Lerner et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of Vascular Endothelial Growth Factor in Kidney Disease

(2010) Kent Doi et al.   Current Vascular Pharmacology

Effects of Vitamin D3 on Expression of Tumor Necrosis Factor-α and Chemokines by Monocytes

(2010) Yu-Ting Kuo et al.   JOURNAL OF FOOD SCIENCE

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

(2010) Dick de Zeeuw et al.   LANCET

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

(2009) Steven Fishbane et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species

(2009) M. J. van den Hoven et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling

(2008) X. Tan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Adriamycin Alters Glomerular Endothelium to Induce Proteinuria

(2008) M. Jeansson et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice

(2008) Chunlei Zhou et al.   KIDNEY INTERNATIONAL

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria

(2007) M.J. van den Hoven et al.   KIDNEY INTERNATIONAL

Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking

(2007) A.L. Rops et al.   KIDNEY INTERNATIONAL